• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MQ

    Marqeta Inc.

    Subscribe to $MQ
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Marqeta, Inc. operates a cloud-based open application programming interface platform that delivers card issuing and transaction processing services to developers, technical product managers, and visionary entrepreneurs. It offers its solutions in the various verticals, including commerce disruptors, digital banks, tech giants, and large financial institutions. The company incorporated in 2010 and is headquartered in Oakland, California.

    IPO Year: 2021

    Exchange: NASDAQ

    Website: marqeta.com

    Peers

    $FISV
    $UPST

    Recent Analyst Ratings for Marqeta Inc.

    DatePrice TargetRatingAnalyst
    5/19/2025$6.00Neutral → Overweight
    Analyst
    12/17/2024$5.00 → $4.00Overweight → Equal Weight
    Barclays
    11/5/2024Buy → Neutral
    Monness Crespi & Hardt
    11/5/2024$9.00 → $4.00Buy → Hold
    Deutsche Bank
    11/5/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    11/5/2024Outperform → Mkt Perform
    William Blair
    11/5/2024$7.00 → $5.00Overweight → Equal Weight
    Wells Fargo
    6/25/2024$7.00Equal Weight → Overweight
    Wells Fargo
    6/24/2024$5.50Neutral
    Goldman
    5/8/2024$7.50 → $8.00Buy
    Monness Crespi & Hardt
    See more ratings